Mustafa Suker - Publications

Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trials.

Journal: The British journal of surgery

Published: August 20, 2025

Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.

Journal: The British journal of surgery

Published: February 08, 2023

The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 24, 2022

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 27, 2022

High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Frontiers in oncology

Published: December 08, 2021

External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible but Nonrandomized Patients.

Journal: Annals of surgery

Published: December 04, 2020

Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).

Journal: Annals of surgery

Published: November 17, 2020

Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: October 23, 2020

A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 29, 2020

Daily dose to organs at risk predicts acute toxicity in pancreatic stereotactic radiotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 25, 2020

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 28, 2020

The yield of chest computed tomography in patients with locally advanced pancreatic cancer.

Journal: Journal of surgical oncology

Published: January 01, 2020